WestGene Biopharma
WestGene Biopharma（威斯津生物）
Licensing announcements since 2025
| Date | Counterparty | Asset / platform | Upfront | Near-term | Potential total | Stage at announcement |
|---|---|---|---|---|---|---|
| 2026-08-28 | CREATE Medicines, Inc. | tLNP platform: CRT-403, CRT-401 and CD19 × BCMA RetroT programs | Not disclosed | Not disclosed | Not disclosed | Not disclosed |